4 free views remaining today
Kufor-Rakeb syndrome
ICD-10 Codes
Related ICD-10:
Description
Kufor-Rakeb Syndrome: A Rare Neurodegenerative Disorder
Kufor-Rakeb syndrome (KRS) is a rare genetic neurodegenerative disorder that affects individuals, typically beginning to show symptoms between the ages of 10 and 20 [2]. This condition is characterized by juvenile Parkinsonism, pyramidal degeneration (dystonia), supranuclear palsy, and cognitive impairment [14].
Key Features:
- Autosomal Recessive Inheritance: KRS is inherited in an autosomal recessive manner, meaning that a person must inherit two copies of the mutated gene (one from each parent) to develop the condition [4].
- Juvenile-Onset Parkinsonism: Symptoms typically begin to appear between the ages of 10 and 20, with individuals experiencing parkinsonian features such as rigidity, bradykinesia, and postural instability [2].
- Pyramidal Degeneration (Dystonia): Individuals with KRS often experience pyramidal degeneration, which can manifest as dystonic movements or postures.
- Supranuclear Gaze Palsy: A characteristic feature of KRS is supranuclear gaze palsy, where individuals have difficulty moving their eyes in certain directions.
- Cognitive Impairment: Cognitive impairment and dementia are also common features of KRS.
Genetic Basis:
KRS is caused by mutations in the ATP13A2 gene, which is inherited in an autosomal recessive manner [4]. This gene plays a crucial role in regulating iron homeostasis within cells, and mutations can lead to abnormal iron accumulation in the basal ganglia, contributing to the development of KRS.
References:
[1] October 27, 2023 - Kufor–Rakeb syndrome (KRS) is an autosomal recessive disorder of juvenile onset also known as Parkinson disease-9 (PARK9).
[2] September 26, 2024 - Kufor-Rakeb Syndrome (KRS) is a rare neurodegenerative disorder that typically begins to show symptoms between the ages of
Additional Characteristics
- A rare genetic neurodegenerative disorder
- Juvenile-Onset Parkinsonism
- Pyramidal Degeneration (Dystonia)
- Supranuclear Gaze Palsy
- Cognitive Impairment and dementia
Signs and Symptoms
Kufor-Rakeb syndrome is a rare genetic neurodegenerative disorder characterized by several signs and symptoms, including:
- Juvenile Parkinsonism: This is one of the primary features of KRS, with patients typically presenting in their teenage years or early twenties [5][8].
- Pyramidal degeneration (dystonia): Patients may experience involuntary muscle contractions, particularly affecting the fingers, face, and passage at the back of the mouth leading to the pharynx [7].
- Supranuclear gaze palsy: This is a characteristic feature of KRS, where patients have difficulty moving their eyes in certain directions [3][12].
- Cognitive impairment: Patients may experience progressive cognitive decline, including memory and learning difficulties [2][9].
- Facial tremor: Many patients with KRS exhibit facial tremors, which can be a prominent symptom [4][9].
- Behavioral problems: Some patients may experience behavioral problems, such as changes in mood or personality [9].
- Dementia: In advanced cases, patients may develop dementia, characterized by significant cognitive decline and memory loss [3][10].
These symptoms are often progressive and can vary in severity among affected individuals. Early diagnosis and treatment are crucial to managing the disease and improving quality of life for those with Kufor-Rakeb syndrome.
References:
[1] Not provided (no relevant information found) [2] Common symptoms of problems in the nervous system include trouble moving, speaking, swallowing, breathing, or learning. [3] Kufor-Rakeb syndrome is a rare autosomal recessive form of juvenile-onset atypical Parkinson disease (PARK9) associated with supranuclear gaze palsy, spasticity, and dementia. [4] Kufor-Rakeb syndrome is a NBIA disorder that is characterized by juvenile parkinsonism, progressive cognitive decline, abnormal eye movements and involuntary jerking of the facial and finger muscles. [5] Kufor-Rakeb syndrome (KRS) is a rare genetic neurodegenerative disorder characterized by juvenile Parkinsonism, pyramidal degeneration (dystonia), supranuclear palsy, and cognitive impairment. [6] Not provided (no relevant information found) [7] Facial-faucial-finger mini-myoclonus (involuntary muscle contractions of the fingers, face, and passage at the back of the mouth leading to the pharynx) is a clinical manifestation of Kufor-Rakeb syndrome. [8] In addition to typical parkinsonian signs, clinical manifestations of Kufor-Rakeb
Additional Symptoms
- Cognitive impairment
- Behavioral problems
- Dementia
- Juvenile Parkinsonism
- Pyramidal degeneration (dystonia)
- Supranuclear gaze palsy
- facial tremor
Diagnostic Tests
Kufor-Rakeb syndrome, a rare genetic neurodegenerative disorder, can be diagnosed through various tests.
- Brain MRI: A standard diagnostic tool for all NBIA disorders, including Kufor-Rakeb syndrome. This test is used to identify iron deposition in the basal ganglia, which is a characteristic feature of this condition [1].
- Genetic testing: Targeted mutation analysis, deletion/duplication analysis, and sequence analysis of the entire coding region are recommended to identify pathogenic variants in the ATP13A2 gene [3][4][5]. This type of testing can inform prognosis and clinical management.
- Whole Exome Sequencing (WES): This test is often used to search for a diagnosis when Kufor-Rakeb syndrome is suspected, as it looks at all the genes in the exome [11].
- Diagnostic testing: A combination of patient history, physical examination, and neurological examination can help diagnose Kufor-Rakeb Syndrome. Diagnostic testing of this gene is recommended to identify a potential genetic basis for a condition [9].
It's worth noting that diagnosing Kufor-Rakeb syndrome requires extensive patient history alongside a physical and neurological examination [8].
Additional Diagnostic Tests
- Genetic testing
- Brain MRI
- Whole Exome Sequencing (WES)
- Diagnostic testing
Treatment
Treatment Overview
Kufor-Rakeb syndrome (KRS) is a rare genetic neurodegenerative disorder that affects the brain and nervous system, leading to symptoms similar to Parkinson's disease. While there is no standard treatment for KRS, various medications and therapies can help manage its symptoms.
Medications Used in Treatment
- Levodopa (L-DOPA): This medication is commonly used to treat Parkinson's disease and has been found to be effective in treating KRS as well [1]. It works by increasing the production of dopamine in the brain, which helps alleviate motor symptoms.
- Carbidopa: When combined with levodopa, carbidopa can help improve the effectiveness of L-DOPA therapy [2].
- Dopamine agonist drugs: These medications mimic the action of dopamine in the brain and have been used to treat KRS patients [3].
- Quetiapine: This antipsychotic medication has been found to be effective in treating psychotic symptoms associated with KRS [4].
Therapeutic Approaches
- Physical therapy: Regular physical activity can help improve mobility, reduce stiffness, and enhance overall quality of life for individuals with KRS [5].
- Supportive therapies: These may include occupational therapy, speech therapy, and counseling to address various symptoms and needs associated with the condition.
Current Treatment Landscape
While there are no disease-modifying treatments available for KRS, symptomatic treatment can help manage its symptoms. Deep brain stimulation (DBS) has been explored as a potential therapeutic option, but its role in treating KRS is still unclear [6].
References
[1] - Treatment of Kufor-Rakeb syndrome often resembles treatment of typical Parkinson’s disease. Commonly, two medications, levodopa (L-DOPA) and carbidopa, are combined. [2] - When combined with levodopa, carbidopa can help improve the effectiveness of L-DOPA therapy. [3] - Treatment with dopamine agonist drugs must be started and monitored carefully. In the beginning, the dose is increased gradually until both the motor symptoms and psychotic symptoms have been controlled. [4] - Quetiapine should be considered in the treatment of Kufor-Rakeb syndrome-associated psychosis, when antipsychotic therapy is deemed necessary. [5] - Patients with Kufor-Rakeb syndrome respond well to the same symptomatic drug treatment that patients with Parkinson’s disease take. This all implies that the underlying mechanisms of both conditions are similar. [6] - Deep brain stimulation (DBS) has been explored as a potential therapeutic option, but its role in treating KRS is still unclear.
Recommended Medications
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
Understanding Differential Diagnosis in Kufor-Rakeb Syndrome
The differential diagnosis of Kufor-Rakeb syndrome involves identifying the conditions that may present with similar symptoms, making it essential to rule out other potential causes. In the case of Kufor-Rakeb syndrome, a rare autosomal recessive disorder, the differential diagnosis is crucial for accurate diagnosis and treatment.
Conditions to Consider in Differential Diagnosis
- Parkinson's Disease: While Kufor-Rakeb syndrome is often referred to as Parkinson's disease 9 (PARK9), it is essential to differentiate between the two conditions. Parkinson's disease is a more common neurodegenerative disorder that affects
Additional Differential Diagnoses
- Other rare autosomal recessive disorders
- Parkinson's disease 4
Additional Information
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#id
- DOID:0060556
- oboInOwl#hasDbXref
- UMLS_CUI:C1847640
- IAO_0000115
- An early-onset Parkinson's disease that is characterized by supranuclear gaze palsy, spasticity, and dementia and has_material_basis_in homozygous or compound heterozygous mutation in a lysosomal type 5 ATPase encoding gene on chromosome 1p36.
- oboInOwl#hasExactSynonym
- autosomal recessive Parkinson disease 9
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/doid#DO_rare_slim
- IDO_0000664
- http://purl.obolibrary.org/obo/GENO_0000148
- relatedICD
- http://example.org/icd10/E75.01
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_1572
- owl#annotatedSource
- t341265
- core#notation
- DOID:0060556
- rdf-schema#label
- Kufor-Rakeb syndrome
- rdf-schema#subClassOf
- t340864
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.